The EPS projection of EXACT Sciences Corporation (NASDAQ:EXAS) for quarter ended 2016-09-30 is $-0.51. A week before, the EPS forecast was $-0.51 against target of $-0.51, a month earlier. This estimate stood at $-0.51 60 days earlier versus forecast of $-0.51 90 days earlier, confirming a deviation of 0%.
EXACT Sciences Corporation (NASDAQ:EXAS) reported that 18 days ago, the positive EPS revisions were 0 and negative revisions at 4.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 0, 2, 0 and 2, respectively.
The downgrade of EPS estimates for EXACT Sciences Corporation (NASDAQ:EXAS) in the preceding 120, 60, 30 and 90 days were 5, 3, 0 and 3, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of EXACT Sciences Corporation (NASDAQ:EXAS) was $-0.51. This projection was computed after accounting 6 calls. As reported on 2016-05-03 the EPS was $-0.49. The change was $0.05, demonstrating a percentage deviation of 9.26%. The projections confirmed a standard deviation of 0.01.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for EXACT Sciences Corporation (NASDAQ:EXAS) stands at $39.203 and the median estimate at $38.4. Almost 3 analysts announced their estimates.
The highest estimate is $40.9 while the lowest target is $38.31 showing standard deviation of 1.47%.
As many as 3 analysts released sales estimates reised in upside while 3 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 3 revised sales number projection on upside while 3 lowered the sales target, demonstrating a deviation of 0%.
A quarter ago, 3 hiked sales estimations and 3 reduced sales forecast. EXACT Sciences Corporation (NASDAQ:EXAS) stated that the change in forecast was -1.239%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...